BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35743138)

  • 1. Function of IRAG2 Is Modulated by NO/cGMP in Murine Platelets.
    Prüschenk S; Schlossmann J
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Functional Features of cGMP Substrate Proteins IRAG1 and IRAG2.
    Prüschenk S; Majer M; Schlossmann J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of PKGIβ/IRAG1 Signaling Causes Anemia-Associated Splenomegaly.
    Majer M; Prueschenk S; Schlossmann J
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRAG2 Interacts with IP
    Prüschenk S; Majer M; Schreiber R; Schlossmann J
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation.
    Antl M; von Brühl ML; Eiglsperger C; Werner M; Konrad I; Kocher T; Wilm M; Hofmann F; Massberg S; Schlossmann J
    Blood; 2007 Jan; 109(2):552-9. PubMed ID: 16990611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation.
    Schinner E; Salb K; Schlossmann J
    Platelets; 2011; 22(3):217-27. PubMed ID: 21244222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.
    Wilson LS; Elbatarny HS; Crawley SW; Bennett BM; Maurice DH
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13650-5. PubMed ID: 18757735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NO/cGMP pathway inhibits Rap 1 activation in human platelets via cGMP-dependent protein kinase I.
    Danielewski O; Schultess J; Smolenski A
    Thromb Haemost; 2005 Feb; 93(2):319-25. PubMed ID: 15711749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.
    Isenberg JS; Romeo MJ; Yu C; Yu CK; Nghiem K; Monsale J; Rick ME; Wink DA; Frazier WA; Roberts DD
    Blood; 2008 Jan; 111(2):613-23. PubMed ID: 17890448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP.
    Butt E; Nolte C; Schulz S; Beltman J; Beavo JA; Jastorff B; Walter U
    Biochem Pharmacol; 1992 Jun; 43(12):2591-600. PubMed ID: 1321624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation.
    Stojanovic A; Marjanovic JA; Brovkovych VM; Peng X; Hay N; Skidgel RA; Du X
    J Biol Chem; 2006 Jun; 281(24):16333-9. PubMed ID: 16613861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
    Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
    Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
    Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
    Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
    Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
    Oda A; Druker BJ; Smith M; Salzman EW
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. InsP3R-associated cGMP kinase substrate (IRAG) is essential for nitric oxide-induced inhibition of calcium signaling in human colonic smooth muscle.
    Fritsch RM; Saur D; Kurjak M; Oesterle D; Schlossmann J; Geiselhöringer A; Hofmann F; Allescher HD
    J Biol Chem; 2004 Mar; 279(13):12551-9. PubMed ID: 14729908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
    Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen.
    Riba R; Sharifi M; Farndale RW; Naseem KM
    Thromb Haemost; 2005 Aug; 94(2):395-403. PubMed ID: 16113831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.